Literature DB >> 11827606

Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents.

H Hannesdóttir1, T Tyrfingsson, J Piha.   

Abstract

Our objectives were to compare behaviour problem scores (BPS) for Icelandic adolescents admitted for detoxification treatment for alcohol and narcotic abuse as compared with the general population, in accordance with the Youth Self Report (YSR), and to describe psychosocial functioning and psychiatric comorbidity for the treated adolescents. The case series consisted of 103 adolescents, ages 12-18 years, who completed the YSR at the end of a 10-day stay at the National Hospital of Addiction Medicine. The total BPS tallied from the YSR items was compared with scores for the general population. The psychiatric comorbidity and psychosocial functioning of the case series were assessed through diagnostic interviews in accordance with DSM-IV and ICD-10 criteria. The BPS for the 36 treated girls was significantly higher than for the general population (104 versus 36) and higher than for the 56 treated boys (82 versus 56) with 2 standard deviations above the norm for the population. Three-quarters of the adolescents had psychiatric comorbidity: conduct disorder (44%), depression (28%), or posttraumatic stress disorder (11%). The findings support the discriminative validity of the YSR as part of a structured global assessment of substance-abusing adolescents, in particular to identify the frequently present psychiatric comorbidities.

Entities:  

Mesh:

Year:  2001        PMID: 11827606     DOI: 10.1080/080394801750093742

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  7 in total

Review 1.  Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review.

Authors:  Christianne Couwenbergh; Wim van den Brink; Kirsten Zwart; Coby Vreugdenhil; Patricia van Wijngaarden-Cremers; Rutger J van der Gaag
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-09       Impact factor: 4.785

2.  Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment.

Authors:  Sarah K Moore; Lisa A Marsch; Gary J Badger; Ramon Solhkhah; Yariv Hofstein
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

3.  Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Authors:  Anne-Marit Langås; Ulrik F Malt; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2011-02-12       Impact factor: 3.630

4.  Alcohol abuse in Russian delinquent adolescents. Associations with comorbid psychopathology, personality and parenting.

Authors:  Roman A Koposov; Vladislav V Ruchkin; Martin Eisemann; Pavel I Sidorov
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-08       Impact factor: 4.785

5.  Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders.

Authors:  Norman Therribout; Emily Karsinti; Alix Morel; Alexandra Dereux; Florence Vorspan; Lucia Romo; Romain Icick
Journal:  Front Psychiatry       Date:  2022-06-28       Impact factor: 5.435

6.  Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders.

Authors:  Tobias Langenbach; Alexandra Spönlein; Eva Overfeld; Gaby Wiltfang; Niklas Quecke; Norbert Scherbaum; Peter Melchers; Johannes Hebebrand
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-09-28       Impact factor: 3.033

7.  Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.

Authors:  Geurt van de Glind; Maija Konstenius; Maarten W J Koeter; Katelijne van Emmerik-van Oortmerssen; Pieter-Jan Carpentier; Sharlene Kaye; Louisa Degenhardt; Arvid Skutle; Johan Franck; Eli-Torild Bu; Franz Moggi; Geert Dom; Sofie Verspreet; Zsolt Demetrovics; Máté Kapitány-Fövény; Melina Fatséas; Marc Auriacombe; Arild Schillinger; Merete Møller; Brian Johnson; Stephen V Faraone; J Antoni Ramos-Quiroga; Miguel Casas; Steve Allsop; Susan Carruthers; Robert A Schoevers; Sara Wallhed; Csaba Barta; Peter Alleman; Frances R Levin; Wim van den Brink
Journal:  Drug Alcohol Depend       Date:  2013-10-05       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.